$10
Vol. 27 No. 03
April 2023
BIOSIMILARS IN 2023
REVOLUTION OR ILLUSION?
Health Could biosimilars be the answer to rising drug costs for group benefits plans? Entrepreneurship Advisors are finding creative ways to help clients who need long-term care insurance Financial planning Protect your clients against sudden decumulation by knowing the warning signs